HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

New study: lower LDL for longer is better, supporting routine ezetimibe add-on (Joel Kahn)

Louis Nervegna · Mar 29, 2026 · ♥ 7 reactions · 0 comments · original Facebook post
PCSK9, ezetimibe & newer drugsStatinsLDL, ApoB & lipid panel
AI summary & key facts

A hashtag-only share of a Joel Kahn post saying a new study supports the principle that lower and longer LDL lowering is better in heart patients, and that routinely adding ezetimibe is a smart path. No study details are given.

#ezpaveHD #ezetimibeHD #statinsHD #statinsezetimibeHD

Shared from Joel Kahn · original post

A new study supports the lower, the longer, the better for LDL cholesterol in heart patients Add Ezetimibe routinely a smart path.

← newer: Americans already eat about 1.5 g/kg of protein per day, welolder: Hormone therapy has no proven dementia benefit and may add r →